Boston Scientific (NYSE:BSX) said it has received FDA approval for its Agent Drug-Coated Balloon for the treatment of coronary in-stent restenosis, the narrowing of a stented blood vessel due to ...

The device uses acoustic pressure waves created in a balloon catheter to fracture calcium buildup on the insides of blood vessels. Boston Scientific, the third-largest medical device-maker in the ...

Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Piper Sandler from $95.00 to $115.00 in a ...

Boston Scientific is diving into the field of intravascular ... Bolt’s technique, currently under development, involves threading a balloon through a calcified artery. Then, laser pulses are ...

Boston Scientific Corporation today announced it ... to fracture calcium by creating acoustic pressure waves inside of a balloon catheter. The system also includes visible, directional emitters ...

The Bolt IVL system is designed to use lithotripsy to fracture calcium by creating acoustic pressure waves inside a balloon catheter. Also Read: Boston Scientific Updates Instructions for ...

Boston Scientific Corporation has entered a definitive agreement to acquire the remaining 74% stake not yet owned in Bolt Medical, in a deal valued at up to $664m. The acquisition includes nearly ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and ...